Abstract:
Systemic sclerosis (SSc) is a connective-tissue disease characterized by excessive collagen deposition and by vascular hyper-reactivity and obliterative microvascular phenomena. In addition to diminishing life expectancy, SSc is responsible for skin, tendon, joint, and vessel damage, which leads to disability, handicap, and worsening of quality of life.
Health related quality of life can be measured in systemic sclerosis patients by using the Medical Outcomes Study 36-Item Short-Form Health Survey and/or the World Health Organization Disability Assessment Schedule II. Health related quality of life has been reported to be compromised in patients with systemic sclerosis.
Not surprisingly, health related quality of life, when measured using the 36-Item Short-Form Health Survey, has been reported to be compromised in patients with systemic sclerosis, and the use of the physical component score of the 36-Item Short-Form Health Survey has been shown to discriminate between patients with limited cutaneous SSc and those with diffuse systemic sclerosis. However, the relevance of using the two aggregate scores, physical component score and the mental component score has not been demonstrated in SSc.
The Health Organization Disability Assessment Schedule II is a multidimensional instrument which has good ability to discriminate between subsets of systemic sclerosis (Classification of Systemic Sclerosis) patients with less severe disease compared with those with more severe disease. In these patients, significant predictors of the Health Organization Disability Assessment Schedule II are skin scores, shortness of breath, number of gastrointestinal problems, fatigue, pain, and depression.
In systemic sclerosis patients health related quality of life is significantly impaired as compared with the healthy population as assessed by the 36-Item Short-Form Health Survey and/or the Health Organization Disability Assessment Schedule II. Whether one of the two or both of these tests are necessary remains to be determined.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- BDI:
-
baseline dyspnea index
- CHFS:
- HAD:
-
hospital anxiety and depression
- HAQ:
-
Health assessment questionnaire
- HRQOL:
-
Health related quality of life
- ICF:
-
International Classification of Functioning, Disability and Health
- MACTAR:
-
McMaster-Toronto Arthritis Patient Preference Disability Questionnaire
- MCS:
-
mental component score
- MHISS:
-
Mouth Handicap In Systemic Sclerosis
- MOS:
-
Medical Outcomes Study
- PCS:
-
physical component score
- SD:
-
standard deviation
- SF-36:
-
36-Item Short-Form Health Survey
- sHAQ:
-
scleroderma HAQ
- SSc:
-
systemic sclerosis
- lSSc:
-
limited SSc
- lcSSc:
-
limited cutaneous SSc
- dSSc:
-
diffuse SSc
- VAS:
-
visual analog scale
- WHODAS II:
-
World Health Organization Disability Assessment Schedule II
References
Tamby MC, Chanseaud Y, Guillevin L, et al. (2003). Autoimmun Rev. 2: 152–157.
LeRoy EC, Medsger TA, Jr. (2001). J Rheumatol. 28: 1573–1576.
Masi AT. (1988). J Rheumatol. 15: 894–898.
Hachulla E, Gressin V, Guillevin L, et al. (2005). Arthritis Rheum. 52: 3792–3800.
Steen VD, Medsger TA Jr. (2000). Arthritis Rheum. 43: 2437–2444.
Steen VD, Medsger TA. (2000). Ann Intern Med. 133: 600–603.
Bouros D, Wells AU, Nicholson AG, et al. (2002). Am J Respir Crit Care Med. 165: 1581–1586.
Poole JL, Steen VD. (1991). Arthritis Care Res. 4: 27–31.
Guyatt GH, Feeny DH, Patrick DL. (1993). Ann Intern Med. 118: 622–629.
O'Reilly S, Dogherty M. (2003). Signs, symptoms and laboratory tests. K. Brandt, M. Dogherty, and L. Lohmander, (Ed). Osteoarthritis. 2nd Edn, In:Oxford University Press: New-York. p. 197–210.
Xie F, Li SC, Fong KY, et al. (2006). Osteoarthritis Cartilage. 14: 224–230.
Ware J, Snow K, Kosinski M, et al. (1993). SF-36 Health Survey: manual and interpretation guide. The Health Institute, New England Medical Center.Boston:
Kosinski M, Keller SD, Hatoum HT, et al. (1999). Med Care. 37: MS10–MS22.
Patrick DL, Deyo RA. (1989). Med Care. 27: S217–S232.
Ware JE Jr., Sherbourne CD. (1992). Med Care. 30: 473–483.
Kosinski M, Keller SD, Ware JE Jr., et al. (1999). Med Care. 37: MS23–MS39.
Del Rosso A, Boldrini M, D'Agostino D, et al. (2004). Arthritis Rheum. 51: 475–481.
Danieli E, Airo P, Bettoni L, et al. (2005). Clin Rheumatol. 24: 48–54.
Georges C, Chassany O, Mouthon L, et al. (2004). Rev Med Interne. 25: 16–21.
Khanna D, Furst DE, Clements PJ, et al. (2005). J Rheumatol. 32: 832–840.
Khanna D, Clements PJ, Furst DE, et al. (2005). Arthritis Rheum. 52: 592–600.
Merkel PA, Clements PJ, Reveille JD, et al. (2003). Report from OMERACT 6. J Rheumatol. 30: 1630–1647.
Khanna D, Ahmed M, Furst DE, et al. (2007). Arthritis Rheum. 57: 86–93.
Rannou F, Poiraudeau S, Berezné A, et al. (2007). Arthritis Rheum. 57(1): 94–102. [Epub ahead of print].
Bowling A, Bond M, Jenkinson C, et al. (1999). J Public Health Med. 21: 255–270.
McHorney CA, Ware JE Jr., Raczek AE. (1993). Med Care. 31: 247–263.
International Classification of Functioning, Disability, and Health., in World Health Organization, n. ed., Editor. 2001: Geneva.
van Tubergen A, Landewe R, Heuft-Dorenbosch L, et al. (2003). Ann Rheum Dis. 62: 140–145.
Poesl M (2004). in URL: http://edoc.ub.uni-muenchen.de/archive/00002533/02/Poesl_Miriam.pdf.
Chwastiak LA, Von Korff M. (2003). J Clin Epidemiol. 56: 507–514.
Hudson M, Steele R, Taillefer S, et al. (2008). Arthritis Rheum. 59: 270–278.
Hudson M, Thombs BD, Steele R, et al. (2008). Arthritis Rheum. 59: 279–284.
Khanna D, Yan X, Tashkin DP, et al. (2007). Arthritis Rheum. 56: 1676–1684.
Kaplan RM, Atkins CJ, Timms R. (1984). J Chronic Dis. 37: 85–95.
Jones PW, Quirk FH, Baveystock CM, et al. (1992). Am Rev Respir Dis. 145: 1321–1327.
Jones PW, Quirk FH, Baveystock CM. (1991). Respir Med. 85(B): 25–31; discussion 33–7.
Nishiyama O, Taniguchi H, Kondoh Y, et al. (2005). Respir Med. 99: 408–414.
Chang JA, Curtis JR, Patrick DL, et al. (1999). Chest. 116: 1175–1182.
Tzanakis N, Samiou M, Lambiri I, et al. (2005). Eur J Intern Med. 16: 105–112.
Beretta L, Santaniello A, Lemos A, Masciocchi M, Scorza R. (2007). Rheumatology (Oxford) 46 2: 296–301.
Poole JL, William CA, Bloch DA, et al. (1995). Arthritis Care Res. 8: 189–193.
Merkel PA, Herlyn K, Martin RW, et al. (2002). Arthritis Rheum. 46: 2410–2420.
Steen VD, Medsger TA. (1997). Arthritis Rheum. 40: 1984–1991.
Clements PJ, Wong WK, Hurwitz EL, et al. (2001). Arthritis Rheum. 44: 653–61.
Brower LM, Poole JL. (2004). Arthritis Rheum. 51: 805–809.
Mouthon L, Rannou F, Berezne A, et al. (2007). Ann Rheum Dis. 66: 1651–1655.
Tugwell P, Bombardier C, Buchanan WW, et al. J Rheumatol. 14: 446–451.
Hewlett S, Smith AP, Kirwan JR. (2001). Ann Rheum Dis. 60: 928–933.
Verhoeven AC, Boers M, van der Liden S. (2000). J Rheumatol. 27: 2801–2809.
Mouthon L, Rannou F, Berezne A, et al. (2008). Arthritis Rheum. 59: 968–973.
Acknowledgements
We thank the Association des sclérodermiques de France for its support.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media LLC
About this entry
Cite this entry
Mouthon, L., Rannou, F., Berezné, A., Poiraudeau, S. (2010). Quality of Life in Systemic Sclerosis. In: Preedy, V.R., Watson, R.R. (eds) Handbook of Disease Burdens and Quality of Life Measures. Springer, New York, NY. https://doi.org/10.1007/978-0-387-78665-0_222
Download citation
DOI: https://doi.org/10.1007/978-0-387-78665-0_222
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-78664-3
Online ISBN: 978-0-387-78665-0
eBook Packages: MedicineReference Module Medicine